Morepen Laboratories informs about updates

04 Jun 2021 Evaluate
Morepen Laboratories has informed that the Securities and Exchange Board of India (‘SEBI’) in the matter of issuance of GDR by Morepen Laboratories (‘the Company’), in its adjudication orders dated May 20, 2021 and May 31, 2021, disposed of the adjudication proceeding, against Sushil Suri, Manoj Joshi, P.S. Pritam and Deepak Gupta, Directors of the company as alleged violation of provisions of SEBI Laws/ Regulations were not established. The adjudication proceedings in respect to P.S. Pritam, were abated due to his sad demise. The company in its communication dated April 25, 2021, had informed that in the aforesaid matter company, Hon’ble Securities Appellate Tribunal (‘SAT’) vide its order passed on April 15, 2021, has quashed and set aside the SEBI order dated September 24, 2019 against the Company.

The above information is a part of company’s filings submitted to BSE.

Morepen Laboratories Share Price

50.25 0.15 (0.30%)
26-Apr-2024 10:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1506.45
Dr. Reddys Lab 6228.60
Cipla 1407.55
Zydus Lifesciences 950.00
Lupin 1612.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.